Some People think the Bid is the most important of all when evaluating a stock. And for this exercise the Bid is important, as well as, the Ask. We will use the Bid and the Ask to help determine if ITKH is undervalued. The Current Bid is .002 and the current Ask is .0026
The Send Global deal has not closed yet- ITKH did receive $250k from CELO - $40k was used to audit ITKH books. $210k is ITKH's keep no matter the final outcome of the Send Global deal.
There has been no details released or #'s given concerning the BioFusion Marketing Deal- This deal could be worth million$ or not- we will have to wait to find out.
ITKH's Revenue and Profit for the 1st 3 Quarters of fiscal year 2013 - were - $8,733,842 and ($47,603)
The 4th Q will tell the tell for ITKH- Can ITKH turn a profit for the year? The good thing about 2013 for ITKH is they have the $210k non refundable deposit from trying to sell Send Global. Even though they can't consider the $210k as revenue- it will put ITKH in the black for the year @ about the same level of cash as last year $150k. so without selling Send Global and without marketing any Biofusion Products- ITKH would continue with a PPS valuation of .003 to .01 -
However, if ITKH does sell Send Global they will have a cash to share ratio of .0072 -